Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.54 (
calpain 3
)
430
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cysteine protease
calpain 3
(
CAPN3
) is essential for normal muscle function, since mutations in
CAPN3
cause limb girdle muscular dystrophy type 2A. Previously, we showed that myoblasts isolated from
CAPN3
knockout (C3KO) mice were able to fuse to myotubes; however, sarcomere formation was disrupted. In this study we further characterized morphological and biochemical features of C3KO myotubes in order to elucidate a role for
CAPN3
during myogenesis. We showed that cell cycle withdrawal occurred normally in C3KO cultures, but C3KO myotubes have an increased number of myonuclei per myotube. We found that
CAPN3
acts during myogenesis to specifically control levels of membrane-associated but not cytoplasmic beta-catenin and
M-cadherin
.
CAPN3
was able to cleave both proteins, and in the absence of
CAPN3
,
M-cadherin
and beta-catenin abnormally accumulated at the membranes of myotubes. Given the role of
M-cadherin
in myoblast fusion, this finding suggests that the excessive myonuclear index of C3KO myotubes was due to enhanced fusion. Postfusion events, such as beta1D integrin expression and myofibrillogenesis, were suppressed in C3KO myotubes. These data suggest that the persistence of fusion observed in C3KO cells inhibits subsequent steps of differentiation, such as integrin complex rearrangements and sarcomere assembly.
...
PMID:Regulation of the M-cadherin-beta-catenin complex by calpain 3 during terminal stages of myogenic differentiation. 1698 91